Shares of Pharming Group N.V. Sponsored ADR (PHAR) have gained 17.9% over the past four weeks to close the last trading session at $12.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$30.67 indicates a potential upside of 145.8%. The average comprises three short-term price targets ranging from a low of $14.00 to a high of$41.00, with a standard deviation of $14.57. While t ...